Shares of Gates-backed Vir Bio tumble after $143M IPO to fund infectious disease efforts by James Thorne on October 11, 2019October 11, 2019 at 3:54 pm It was a rough Wall Street debut for Vir Biotechnology, a San Francisco company with ambitious plans to battle infectious diseases. After raising $143 million in an initial public offering… Read More